Continuous Glucose Monitoring in General Wards for Prevention of Hypoglycemia: Results From the Glucose Telemetry System Pilot Study
Open Access
- 28 November 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 14 (4) , 783-790
Abstract
Limited evidence is available about the use of continuous glucose monitoring (CGM) in general wards. In this pilot study we evaluated the use of the glucose telemetry system (GTS) using CGM technology and remote monitoring to prevent inpatient hypoglycemia in high-risk insulin-treated patients with type 2 diabetes (DM2). A prospective, single-center, randomized pilot study was conducted to determine whether GTS can prevent inpatient hypoglycemia. Patients were randomized to standard of care with point-of-care glucose testing or to the intervention group with GTS. Both groups used CGM (blinded vs real time). Our primary goal was prevention of inpatient hypoglycemia. A total of 13 subjects completed the study: 7 in the standard of care and 6 in the intervention group. The hypoglycemia event rate was 0.20 ± 0.23 episodes/day in standard of care vs 0.07 ± 0.11 episodes/day in the intervention group (P = .31). Six hypoglycemic events occurred in the standard of care vs two in the intervention group. Percentage of time spent <70 mg/dL was 2.44% ± 3.86% vs 0.30% ± 0.39% (P = .54) and time spent <54 mg/dL was 0.29% ± 0.47% vs 0% (P = .19) in the standard-of-care and intervention groups, respectively. Utilizing GTS for DM2 insulin-treated patients in the general wards may be beneficial in reducing hypoglycemia. Based on the results of our pilot study we have initiated a large-scale randomized-controlled trial to further evaluate GTS in the general wards in patients with DM2 at high risk for inpatient hypoglycemia.Keywords
Funding Information
- Baltimore Geriatrics Research, Education and Clinical Center
- Institute of Clinical and Translational Sciences (UL1TR002378)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072488)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK111024)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 HL127422)
- National Institute of Diabetes and Digestive and Kidney Diseases (R18 DK110955)
- National Institute of Diabetes and Digestive and Kidney Diseases (R34DK102177)
- VA Merit Award (#I01 CX001825)
- National Institute on Aging (P30AG028747)
This publication has 40 references indexed in Scilit:
- Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized PatientsDiabetes Care, 2013
- Hypoglycemia in Non-Critically Ill, Hospitalized Patients With Diabetes: Evaluation, Prevention, and ManagementHospital Practice, 2013
- Hypoglycemia-associated Mortality Is Not Drug-associated but Linked to ComorbiditiesThe American Journal of Medicine, 2011
- Weight-Based, Insulin Dose–Related Hypoglycemia in Hospitalized Patients With DiabetesDiabetes Care, 2011
- Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)Diabetes Care, 2011
- Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General WardDiabetes Care, 2009
- American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic ControlDiabetes Care, 2009
- Economic and Clinical Impact of Inpatient Diabetic HypoglycemiaEndocrine Practice, 2009
- Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary diseaseThorax, 2006
- Management of Diabetes and Hyperglycemia in HospitalsDiabetes Care, 2004